MEDSIR is an international private company that was founded by scientific experts in oncology back in 2012. We are dedicated to the design and management of strategic clinical trials in oncology, from the initial study conception to the final publication of results.

We act as the link between our international network of brilliant oncology investigators and the parties (Pharma Companies, Biotechs, Public Institutions, etc.) interested in providing the funding for their clinical research ideas. We help transform the most promising concepts from all around the world into strategic clinical trials that promote patient benefit, scientific advancement, and efficient drug development.

Today we support more than 200 ideas involving the most innovative drugs on the market and in development, optimizing every step of investigator-initiated research. Our international team of high-level clinicians and research experts are passionate about collaborating with top medical oncologists and pharmaceutical companies in order to help them develop the best treatments for patients as quickly as possible.